Karen L. Smith - 02 Jul 2024 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Issuer symbol
SKYE
Transactions as of
02 Jul 2024
Net transactions value
$0
Form type
3
Filing time
05 Jul 2024, 08:58:38 UTC
Previous filing
06 Jun 2024
Next filing
05 Sep 2024

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney